Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting Lipoprotein(a): A New Era in Cardiovascular Disease Prevention.

Methodist DeBakey cardiovascular journal - 1 Jan 2026

Bene-Alhasan Yakubu, Nambi Vijay, Abushamat Layla A, Ballantyne Christie M

Abstract excerpt

Lipoprotein(a), or Lp(a), is a genetically determined low-density lipoprotein-like particle that is elevated in approximately one in five individuals worldwide and represents an independent causal risk factor for atherosclerotic cardiovascular disease and calcific aortic stenosis. Elevated Lp(a) levels contribute significantly to residual cardiovascular risk despite optimal management of traditional risk factors....

Read the complete abstract on PubMed

Topics

Humans
Lipoprotein(a)
Cardiovascular Diseases
Hypolipidemic Agents
Animals
Treatment Outcome
Heart Disease Risk Factors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Biomarkers

Risk Factors

Genetic Predisposition to Disease

Dyslipidemias

Source

Open in PubMed Open full text

Identifiers

PMID: 42761946
DOI: 10.14797/mdcvj.1836
PMCID: PMC13588214

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 15 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting Lipoprotein(a): A New Era in Cardiovascular Disease Prevention.PMID 42761946Read ↗

Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factorSemantic proximity Read ↗

LP(a): Structure, Genetics, Associated Cardiovascular Risk, and Emerging TherapeuticsSemantic proximity Read ↗

Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?Semantic proximity Read ↗

Lipoprotein(a): new insights from modern genomicsSemantic proximity Read ↗

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?Semantic proximity Read ↗

Lipoprotein(a): more interesting than ever after 50 years.Semantic proximity Read ↗

Treatment of Lp(a): Is It the Future or Are We Ready Today?Semantic proximity Read ↗

Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies.Semantic proximity Read ↗

Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations.Semantic proximity Read ↗

Lipoprotein(a)Semantic proximity Read ↗

Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) MoleculeSemantic proximity Read ↗

New Horizons: Revival of Lipoprotein (a) as a Risk Factor for Cardiovascular DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.